166 related articles for article (PubMed ID: 20334883)
1. Decreased level of 5-methyltetrahydrofolate: a potential biomarker for pre-symptomatic amyotrophic lateral sclerosis.
Zhang X; Chen S; Li L; Wang Q; Le W
J Neurol Sci; 2010 Jun; 293(1-2):102-5. PubMed ID: 20334883
[TBL] [Abstract][Full Text] [Related]
2. Folic acid protects motor neurons against the increased homocysteine, inflammation and apoptosis in SOD1 G93A transgenic mice.
Zhang X; Chen S; Li L; Wang Q; Le W
Neuropharmacology; 2008 Jun; 54(7):1112-9. PubMed ID: 18436268
[TBL] [Abstract][Full Text] [Related]
3. Reductions of docosahexaenoic acid-containing phosphatidylcholine levels in the anterior horn of an ALS mouse model.
Arima H; Omura T; Hayasaka T; Masaki N; Hanada M; Xu D; Banno T; Kobayashi K; Takeuchi H; Kadomatsu K; Matsuyama Y; Setou M
Neuroscience; 2015 Jun; 297():127-36. PubMed ID: 25841322
[TBL] [Abstract][Full Text] [Related]
4. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
[TBL] [Abstract][Full Text] [Related]
5. Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
Niessen HG; Debska-Vielhaber G; Sander K; Angenstein F; Ludolph AC; Hilfert L; Willker W; Leibfritz D; Heinze HJ; Kunz WS; Vielhaber S
Eur J Neurosci; 2007 Mar; 25(6):1669-77. PubMed ID: 17432958
[TBL] [Abstract][Full Text] [Related]
6. Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Krishnan J; Vannuvel K; Andries M; Waelkens E; Robberecht W; Van Den Bosch L
J Neurochem; 2008 Sep; 106(5):2170-83. PubMed ID: 18624915
[TBL] [Abstract][Full Text] [Related]
7. Serum matrix metalloproteinase-9 activity is dysregulated with disease progression in the mutant SOD1 transgenic mice.
Soon CP; Crouch PJ; Turner BJ; McLean CA; Laughton KM; Atkin JD; Masters CL; White AR; Li QX
Neuromuscul Disord; 2010 Apr; 20(4):260-6. PubMed ID: 20097566
[TBL] [Abstract][Full Text] [Related]
8. Serial in vivo imaging of transplanted allogeneic neural stem cell survival in a mouse model of amyotrophic lateral sclerosis.
Srivastava AK; Gross SK; Almad AA; Bulte CA; Maragakis NJ; Bulte JWM
Exp Neurol; 2017 Mar; 289():96-102. PubMed ID: 28038988
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of neural and cell cycle-related microRNAs in brain of amyotrophic lateral sclerosis mice at late disease stage.
Marcuzzo S; Bonanno S; Kapetis D; Barzago C; Cavalcante P; D'Alessandro S; Mantegazza R; Bernasconi P
Mol Brain; 2015 Jan; 8():5. PubMed ID: 25626686
[TBL] [Abstract][Full Text] [Related]
10. Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model.
Wang R; Zhang D
Eur J Neurosci; 2005 Nov; 22(9):2376-80. PubMed ID: 16262676
[TBL] [Abstract][Full Text] [Related]
11. Region-specific changes in the immunoreactivity of SIRT1 expression in the central nervous system of SOD1(G93A) transgenic mice as an in vivo model of amyotrophic lateral sclerosis.
Lee JC; Shin JH; Park BW; Kim GS; Kim JC; Kang KS; Cha CI
Brain Res; 2012 Jan; 1433():20-8. PubMed ID: 22137654
[TBL] [Abstract][Full Text] [Related]
12. Amino acids as biomarkers in the SOD1(G93A) mouse model of ALS.
Bame M; Grier RE; Needleman R; Brusilow WS
Biochim Biophys Acta; 2014 Jan; 1842(1):79-87. PubMed ID: 24129262
[TBL] [Abstract][Full Text] [Related]
13. Expression of heat shock transcription factor 1 and its downstream target protein T-cell death associated gene 51 in the spinal cord of a mouse model of amyotrophic lateral sclerosis.
Mimoto T; Morimoto N; Miyazaki K; Kurata T; Sato K; Ikeda Y; Abe K
Brain Res; 2012 Dec; 1488():123-31. PubMed ID: 23063459
[TBL] [Abstract][Full Text] [Related]
14. Regulation of system x(c)- in the SOD1-G93A mouse model of ALS.
Albano R; Liu X; Lobner D
Exp Neurol; 2013 Dec; 250():69-73. PubMed ID: 24041987
[TBL] [Abstract][Full Text] [Related]
15. Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice.
Zhao CP; Zhang C; Zhou SN; Xie YM; Wang YH; Huang H; Shang YC; Li WY; Zhou C; Yu MJ; Feng SW
Cytotherapy; 2007; 9(5):414-26. PubMed ID: 17786603
[TBL] [Abstract][Full Text] [Related]
16. Plasma neurofilament heavy chain levels correlate to markers of late stage disease progression and treatment response in SOD1(G93A) mice that model ALS.
Lu CH; Petzold A; Kalmar B; Dick J; Malaspina A; Greensmith L
PLoS One; 2012; 7(7):e40998. PubMed ID: 22815892
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis.
Toivonen JM; Manzano R; Oliván S; Zaragoza P; García-Redondo A; Osta R
PLoS One; 2014; 9(2):e89065. PubMed ID: 24586506
[TBL] [Abstract][Full Text] [Related]
18. Mislocalization of TDP-43 in the G93A mutant SOD1 transgenic mouse model of ALS.
Shan X; Vocadlo D; Krieger C
Neurosci Lett; 2009 Jul; 458(2):70-4. PubMed ID: 19379791
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study on the distribution of insulin-like growth factor-binding protein 4 in the central nervous system of SOD1(G93A) transgenic mice as an in vivo model of amyotrophic lateral sclerosis.
Kang DW; Chung YH; Lee JC; Bang JS; Kim D; Kim SS; Kim KY; Lee WB; Cha CI
Ann Anat; 2008 Dec; 190(6):502-9. PubMed ID: 18823765
[TBL] [Abstract][Full Text] [Related]
20. A role for the urokinase-type plasminogen activator system in amyotrophic lateral sclerosis.
Glas M; Popp B; Angele B; Koedel U; Chahli C; Schmalix WA; Anneser JM; Pfister HW; Lorenzl S
Exp Neurol; 2007 Oct; 207(2):350-6. PubMed ID: 17716658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
